Kalbe Farma Tbk PT banner

Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 865 IDR -4.95% Market Closed
Market Cap: Rp40.5T

Kalbe Farma Tbk PT
Change in Working Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kalbe Farma Tbk PT
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Kalbe Farma Tbk PT
IDX:KLBF
Change in Working Capital
-Rp12T
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
-5%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Change in Working Capital
-Rp953.5B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Change in Working Capital
-Rp458.3B
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Soho Global Health Tbk PT
IDX:SOHO
Change in Working Capital
-Rp1.5T
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Change in Working Capital
-Rp832.2B
CAGR 3-Years
-89%
CAGR 5-Years
-65%
CAGR 10-Years
-32%
Kimia Farma Tbk PT
IDX:KAEF
Change in Working Capital
-Rp3.9T
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-10%
No Stocks Found

Kalbe Farma Tbk PT
Glance View

Kalbe Farma Tbk PT is a renowned pharmaceutical powerhouse rooted in Indonesia, rooted in a rich history that traces back to 1966. The company has evolved from a humble startup into a multifaceted entity with a robust portfolio, making it a vital player in the health and wellness sector across Southeast Asia. The company operates across four main business divisions: prescription pharmaceuticals, consumer health products, nutritionals, and distribution & logistics. By strategically linking these divisions, Kalbe Farma masterfully balances scientific innovation with market accessibility, ensuring a wide reach and varied product offering. This diversification not only broadens its revenue streams but also mitigates risk, securing its foothold in the competitive pharmaceutical landscape. At the core of Kalbe Farma’s business model lies a commitment to research and development, which fuels its cutting-edge product innovations and enhances its competitive edge. The company dedicates substantial resources to developing new medicines and health products, constantly seeking to address emerging health concerns. Moreover, its extensive distribution network fortifies its market presence, comprising a domestic distribution arm that penetrates even the farthest reaches of the Indonesian archipelago. This network ensures that Kalbe's products are widely available, amplifying their market penetration and revenue. Additionally, Kalbe embraces partnerships and collaborations to enhance its research capabilities and expand its product offerings, fostering an ecosystem where innovation and accessibility coexist harmoniously, thereby empowering its bottom line.

KLBF Intrinsic Value
1 375.51 IDR
Undervaluation 37%
Intrinsic Value
Price Rp865

See Also

What is Kalbe Farma Tbk PT's Change in Working Capital?
Change in Working Capital
-12T IDR

Based on the financial report for Dec 31, 2025, Kalbe Farma Tbk PT's Change in Working Capital amounts to -12T IDR.

What is Kalbe Farma Tbk PT's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-5%

Over the last year, the Change in Working Capital growth was -15%. The average annual Change in Working Capital growth rates for Kalbe Farma Tbk PT have been -7% over the past three years , -8% over the past five years , and -5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett